Company intelligence / Profile preview

Clinical Network

Brisbane, Queensland, Australia

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Clinical Network Services (CNS) is a leading Australian-based contract research organization (CRO) that provides comprehensive product development services to the international biotechnology and pharmaceutical industries. The company specializes in integrated development planning and the management of early-phase clinical trials, leveraging Australia's favorable regulatory environment and R&D tax incentives. CNS offers a full suite of services including clinical trial management, biometrics, medical writing, and regulatory affairs. In 2018, the company was acquired by Pharmaron, a global R&D service provider, to enhance its early-stage clinical development capabilities in the Asia-Pacific region.

Industry: Contract Research Organization

Partnerships

Pharmaron

Beyond the preview

Go deeper on Clinical Network.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clinical Network.

Explore the full profile